Navigation Links
Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Date:3/22/2011

MALVERN, Pa., March 22, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) and Asahi Kasei Pharma Corporation announced today that they have entered into a long-term strategic alliance for the development, commercialization and supply of XIAFLEX® (collagenase clostridium histolyticum), a novel, first-in-class biologic for the treatment of Dupuytren's contracture and Peyronie's disease.  Under the terms of the agreement, Asahi Kasei Pharma will receive exclusive rights to commercialize XIAFLEX for the treatment of Dupuytren's contracture and Peyronie's disease in Japan.  Asahi Kasei Pharma will be primarily responsible for the clinical development, regulatory and commercialization activities for XIAFLEX in Japan.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

XIAFLEX has been approved by the U.S. Food and Drug Administration and the European Commission for the treatment of Dupuytren's contracture.  Asahi Kasei Pharma expects to begin clinical trials for XIAFLEX for the treatment of Dupuytren's contracture in 2012.  XIAFLEX is also being evaluated in a global phase III development program for Peyronie's disease with top line data expected in the first half of 2012.

"Today, Asahi Kasei Pharma and Auxilium have forged a partnership, which we believe has the opportunity to offer the first, effective nonsurgical treatment for two diseases in Japan," said Armando Anido, Chief Executive Officer and President of Auxilium.  "With the strength of Asahi Kasei Pharma's development and commercialization organizations in Japan, we believe this relationship greatly enhances our ability to effectively introduce this potentially groundbreaking product."

Asahi Kasei Pharma will pay Auxilium $15 million upfront. Under the terms of the agreement, Asahi Kasei Pharma will also make up to $247 million in potential mi
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
2. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
3. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
4. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
5. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
6. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
7. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
8. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
9. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... China , Jan. 23, 2015 Tianyin Pharmaceutical ... company that specializes in the development and sale of ... generics and active pharmaceutical ingredients (API) today announced the ... (JCM) API operation. 1. Following the September ...
(Date:1/22/2015)... , Jan. 22, 2015  BiOptix is pleased to ... as Vice President of Chemistry and Biochemistry. Scott joins the ... AstraZeneca Pharmaceuticals, and Amgen throughout the course of his ... "Scott is a nationally recognized thought leader ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
(Date:1/22/2015)... City, Florida (PRWEB) January 22, 2015 IsoComforter, ... cold therapy machine with patented IsoTube design to treat specific ... has introduced the most progressive and easy to use patented ... treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
(Date:1/22/2015)... January 22, 2015 Step into a ... the Science Museum of Virginia. Wicked Plants, the Museum’s ... Plants unearths 75 poisonous, carnivorous and diabolical plants inside ... room to uncover the biochemical, physical and neurological processes ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... HealthDay Reporter , WEDNESDAY, April 11 (HealthDay News) -- ... of the postoperative experience of four children who all carried ... to three of the patients, while a similar case came ... genetic cases, the common painkiller codeine can be lethal. The ...
... published article in the journal Nursing for Women,s Health ... her childbearing. The author asserts that contraception is a means ... care providers to ensure they are healthy prior to conceiving ... According to the Centers for Disease Control and Prevention ...
... Regular walking can help reduce fatigue in some pancreatic cancer ... white men and women aged 66 or 67 who underwent ... before they were discharged from the hospital. One group ... a walking or exercise routine. The other group was told ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, April ... birth controls pills containing drospirenone -- a man-made version of ... risk of blood clots and will require new labels. ... will inform users that the pills -- which include products ...
... April 11, 2012. Anna M. Barrett, MD will represent ... American Academy of Neurology Conference at the Ernest N. ... April 28. Four abstracts will be presented ... of spatial neglect after right-brain stroke. Spatial neglect is ...
... that women are less likely than men to get at ... odds of developing metabolic syndrome a risky and increasingly ... name for a group of risk factors including high ... part of the body which occur together and increase ...
Cached Medicine News:Health News:Codeine After Surgery Could Endanger Certain Kids: Study 2Health News:Codeine After Surgery Could Endanger Certain Kids: Study 3Health News:Codeine After Surgery Could Endanger Certain Kids: Study 4Health News:Timing pregnancy an important health concern for women 2Health News:Short Walks May Ease Fatigue in Pancreatic Cancer Patients 2Health News:Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA 2Health News:NJ stroke researchers report advances in spatial neglect research at AAN Conference 2Health News:Study: Women not getting enough exercise; at risk of developing metabolic syndrome 2
Inquire...
... performance, the SZX7 is designed for ease ... task, from routine preparations to advanced research. ... zoom ratios in its class as well ... accurate reproduction of the original specimen in ...
The Stereomicroscope Stemi 2000 meets your demands in two respects. On the one hand it offers the low-price advantage common with Greenough-type instruments, on the other hand it features superior pe...
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
Medicine Products: